REGENERON PHARMACEUTICALS H-1B Visa Sponsorship & Salary Data

The median H-1B salary at REGENERON PHARMACEUTICALS is $142,485, based on 1,036 certified filings from FY 2020 to FY 2026. This is 19% higher than the national H-1B median salary of $120,000. Compensation at REGENERON PHARMACEUTICALS reflects their market positioning, with entry-level roles starting around $116,358 and senior positions reaching $199,351 or higher. These figures represent base salaries in LCA filings and may not include bonuses, equity grants, or other compensation common at large employers.

Salaries at REGENERON PHARMACEUTICALS range from $94,038 at the 10th percentile to $199,351 at the 90th percentile, showing a $105,313 spread across experience levels and roles. The 25th percentile is $116,358 and the 75th percentile is $167,000.

Yes, REGENERON PHARMACEUTICALS actively sponsors H-1B visas in FY 2026. In the most recent fiscal year (FY 2026), REGENERON PHARMACEUTICALS filed 264 H-1B labor condition applications with 263 certified and 0 denied, at a median salary of $153,063. Across FY 2020–2026, they have filed 1,044 total H-1B applications with 1,036 certified and a 0% lifetime denial rate, demonstrating ongoing commitment to hiring international talent. REGENERON PHARMACEUTICALS sponsors positions across multiple job categories and locations, making them a viable option for professionals seeking H-1B visa sponsorship.

In the most recent fiscal year (FY 2026), REGENERON PHARMACEUTICALS filed 264 H-1B applications, with 263 certified and 0 denied. Over 7 years of data, REGENERON PHARMACEUTICALS has consistently demonstrated commitment to H-1B sponsorship.

Note: These are Labor Condition Applications (LCAs) filed with the Department of Labor, which is a prerequisite for H-1B petitions. The actual number of H-1B petitions filed with USCIS may differ.

REGENERON PHARMACEUTICALS's LCA (Labor Condition Application) denial rate is 0%, with 0 out of 1,044 applications denied across all years. This translates to a 100.0% certification rate, which indicates how successfully the company prepares and files H-1B applications. A lower denial rate suggests better compliance with Department of Labor requirements, proper wage documentation, and accurate job classification. Prospective H-1B applicants should consider this approval rate alongside other factors like salary, job role, and location when evaluating REGENERON PHARMACEUTICALS as a potential H-1B sponsor.

This is an excellent approval rate, indicating REGENERON PHARMACEUTICALS has strong H-1B sponsorship practices and typically meets DOL requirements. Applicants can feel confident in the company's H-1B track record.

REGENERON PHARMACEUTICALS sponsors H-1B visas for various specialty occupation positions requiring at least a bachelor's degree. Based on 1,036 certified filings, the most commonly sponsored job titles reflect the company's primary business functions and talent needs. These positions typically require specialized knowledge in fields like technology, engineering, finance, or scientific research. Understanding which roles REGENERON PHARMACEUTICALS most frequently sponsors can help job seekers target their applications effectively.

Most common H-1B job titles at REGENERON PHARMACEUTICALS:

The most frequently sponsored role is Senior Research Scientist with 140 filings at a median salary of $136,890. This is followed by Research Scientist (91 filings) and Principal Research Scientist.

REGENERON PHARMACEUTICALS's H-1B positions are distributed across multiple U.S. locations, with concentration in major metropolitan areas and tech hubs. Geographic distribution often reflects company office locations, client sites, and regional market demands. Location significantly impacts H-1B salary due to varying cost of living and local wage requirements. Understanding where REGENERON PHARMACEUTICALS sponsors H-1B workers can help candidates target specific offices and negotiate appropriate compensation for each market.

Top REGENERON PHARMACEUTICALS H-1B locations:

The largest H-1B hub for REGENERON PHARMACEUTICALS is Tarrytown, NY with 635 filings at a median salary of $137,970. The highest-paying location is Armonk, NY at $186,622 median. Salaries range from $104,856 to $186,622 across office locations.

REGENERON PHARMACEUTICALS's median H-1B salary has increased by +24% from FY 2020 ($123,000) to FY 2026 ($153,063). Tracking salary trends over time reveals how REGENERON PHARMACEUTICALS adjusts compensation to remain competitive in the H-1B labor market. Salary growth typically reflects inflation adjustments, increased demand for specialized skills, and evolving prevailing wage requirements. These historical trends can help applicants understand future salary expectations and negotiate appropriately when considering H-1B opportunities at REGENERON PHARMACEUTICALS.

Year-by-year breakdown:

• FY 2022: $135,000 (138 certified)
• FY 2023: $140,000 (126 certified)
• FY 2024: $146,016 (129 certified)
• FY 2025: $149,471 (153 certified)
• FY 2026: $153,063 (263 certified)

This 24% growth reflects strong compensation adjustments at REGENERON PHARMACEUTICALS, keeping pace with market demands for H-1B talent.

REGENERON PHARMACEUTICALS primarily files H-1B applications at Wage Level II, accounting for 48% of their filings. DOL wage levels range from Level I (entry-level, 17th percentile of local wages) to Level IV (expert, 67th percentile). Wage level determines both salary requirements and, under recent H-1B rules, lottery selection priority. Higher wage levels receive preference in the H-1B lottery, making REGENERON PHARMACEUTICALS's wage level distribution an important factor for prospective applicants assessing their chances of H-1B selection.

With 99% of positions at Level II or higher, REGENERON PHARMACEUTICALS typically offers competitive wages above entry-level. Higher wage levels receive priority in the H-1B lottery.

REGENERON PHARMACEUTICALS's median H-1B salary of $142,485 is 19% higher than the national H-1B median of $120,000 across all employers and industries. This comparison provides context for evaluating REGENERON PHARMACEUTICALS's competitiveness in attracting H-1B talent. Keep in mind that industry, location, and job function significantly impact salary levels. Tech companies and financial institutions typically offer higher H-1B salaries than other sectors, while salaries in major metros like San Francisco and New York exceed those in smaller markets. Compare REGENERON PHARMACEUTICALS's offerings with similar companies in your field for a more accurate assessment.

REGENERON PHARMACEUTICALS offers above-average H-1B compensation. Combined with their 1,036 certified filings and 0% denial rate, they demonstrate solid H-1B sponsorship practices.

Recent H-1B rule changes have increased filing fees and introduced wage-level prioritization in the lottery. REGENERON PHARMACEUTICALS's higher proportion of Level III-IV positions (51%) may benefit from wage-based lottery prioritization.

With 1,036 certified filings, REGENERON PHARMACEUTICALS invests significantly in H-1B sponsorship. The company's 0% denial rate suggests strong compliance with H-1B requirements and documentation standards.

Note: H-1B regulations are subject to change. Fees shown are estimates based on 2024 USCIS fee schedules. Actual costs may vary based on company size, premium processing, and future rule changes.